27-Apr-2016 - LANXESS AG

LANXESS takes over Chemours’ Clean and Disinfect specialties business

First acquisition after successful completion of realignment program

Specialty chemicals company LANXESS is expanding its portfolio of material protection products by taking over the Clean and Disinfect business of US-based chemical company Chemours. The business comprises active ingredients as well as specialty chemicals used especially in disinfectant and hygiene solutions.

Both companies have now signed an acquisition agreement. The enterprise value of around EUR 210 million will be paid by LANXESS from existing liquidity. Closing is expected in the second half of 2016. The transaction is still subject to approval from the relevant antitrust authorities.

The acquisition will be earnings per share (EPS) accretive in the first fiscal year. The acquired business is expected to generate an annual EBITDA contribution of around EUR 20 million, which will increase gradually with synergy effects to roughly EUR 30 million by 2020.

The deal is LANXESS’ first acquisition after the completion of its realignment program. “We plan to enhance our position particularly in mid-sized, less cyclical markets with high margins and sound growth prospects,” said Matthias Zachert, Chairman of the Board of Management of LANXESS AG. “We have made quick headway and are now expanding our specialty chemicals portfolio which will make us more profitable and more resilient.”

LANXESS takes over Chemours‘ Clean and Disinfect business with 170 employees worldwide and three production sites in Memphis and North Kingstown, USA, and Sudbury, United Kingdom. In 2015, the business achieved sales of around EUR 100 million, roughly half of which in the region of North America. “Through the acquisition, we will grow especially in the region of North America, where we still see good opportunities,” said Zachert.

The new business will be integrated into LANXESS’ Material Protection Products business unit. “With the acquisition of Chemours’ Clean and Disinfect business, we are not only expanding our portfolio of active ingredients, but are also able to establish a forward integrated value chain in the veterinary disinfection segment,” said Michael Schäfer, head of the Material Protection Products business unit. “Above, we will benefit from Chemours’ experienced and dedicated employees, its strong technical and regulatory expertise, its widely recognized brands and well-established distribution networks.”

Chemours’ Clean and Disinfect business is comprised of three segments: disinfectants, potassium monopersulfate and chlorine dioxide.

The segment of disinfectants focuses on providing solutions for veterinary disinfection. Its core product, the powder disinfectant marketed under the brand name Virkon S, has proved to be successful against a multitude of viruses, bacteria and fungi. It is deployed, among others, to combat major diseases such as Foot-and-Mouth disease, Swine Vesicular disease or Avian Influenza.

The second segment deals with the production and distribution of the active ingredient potassium monopersulfate with its core brand Oxone. It is used for pool and spa applications, in personal care, in the electronics industry and as active ingredient in the formulation of disinfection products, especially in Virkon branded products.

The chlorine dioxide segment is an established provider of package solutions for industrial water treatment.

Facts, background information, dossiers
  • potassium monopersulfate
  • hygiene
More about Lanxess
  • News

    LANXESS increases black pigment capacity

    Specialty chemicals company LANXESS has expanded its capacity for black synthetic iron oxide pigments at its Krefeld-Uerdingen site by more than 5,000 metric tons per year. “The increased demand from the construction industry, in particular for our unique black pigments to color concrete, c ... more

    LANXESS plans to expand capacity for Oxone monopersulfate - a main active ingredient for disinfectants

    Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro sum in its production facility ... more

    LANXESS remains robust: Guidance for 2020 confirmed

    LANXESS is continuing to weather the crisis well and is confirming its forecast for the full year. The specialty chemicals company still anticipates EBITDA pre exceptionals of between EUR 800 million and EUR 900 million for 2020. In the second quarter of 2020, LANXESS recorded a significant ... more

  • Companies

    LANXESS Deutschland GmbH

    LANXESS is a leading specialty chemicals company and operates in all important markets of the world. Its core business comprises the development, manufacture and sale of high-tech plastics, high-performance rubber, specialty chemicals and intermediates. In addition, it helps its customers i ... more


    LANXESS is listed as the fourth largest German Chemistry Corporation in the Frankfurt Stock Exchange. With our extensive portfolio we are active in all the markets of the world. Our product pallet ranges from base, specialty and fine chemicals to plastics and rubbers. In addition, we sup ... more

    LANXESS Sybron Chemicals Inc.

    LANXESS Sybron Chemicals Inc., provides world-class ion exchange resins to meet the needs of numerous applications. The global strength of Lewatit ion exchange resins in industrial water and chemical processing markets is joined with the solid position Ionac ion exchange resins enjoy in the ... more

More about Chemours
  • News

    LANXESS closes acquisition of Chemours' Clean and Disinfect business

    Specialty chemicals company LANXESS closed the acquisition of the Clean and Disinfect business of U.S.-based chemicals company Chemours on August 31, 2016. All relevant antitrust authorities have approved the transaction. LANXESS has paid around EUR 210 million for the Clean and Disinfect b ... more

    Chemours Breaks Ground for World’s First Full-Scale Production of HFO-1336mzz

    The Chemours Company announced that, along with its partner Changshu 3F Zhonghao, it has broken ground on the world’s first full-scale production facility for HFO-1336mzz in Changshu, Jiangsu Province, China. This site, expected to begin production mid-year 2017, will provide increased capa ... more

    Chemours Consolidates and Strengthens TiO2 Business

    The Chemours Company announced two decisions that are elements of the company's five-point transformation plan. The company will close its Edge Moor manufacturing site located outside Wilmington, Delaware, which produces titanium dioxide (TiO2) and will shut down a TiO2 line (line 3) at its ... more

  • Companies

    Chemours International Operations Sarl

    The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-d ... more